Abstract
In order to delineate the exact role of bursectomy (BS) in gastric cancer surgery, we designed and conducted the present meta-analysis. This meta-analysis adhered to the PRISMA guidelines and the Cochrane Handbook for Systematic Reviews of Interventions. A systematic literature review of the electronic databases (Medline, Scopus, Web of Science) was performed. Trial sequential analysis (TSA) was introduced for the validation of the pooled analyses. The level of evidence was attributed based on the GRADE approach. Overall, nine studies and 3599 patients were included in our meta-analysis. BS did not lead to an increase in the overall morbidity rate (OR 1.17, 95% CI 0.97–1.42, p = 0.09). Equivalence was, also, identified in all specific postoperative complications. Similarly, mortality rates were comparable (p = 0.69). Moreover, BS was related to a significantly higher operative time (p < 0.001) and perioperative blood loss (p = 0.002). Finally, resection of the omental bursa was not associated with improved R0 excision rates (p = 0.92), lymph node harvest (p = 0.1) or survival outcomes (OS p = 0.15 and DFS p = 0.97). BS displayed a suboptimal perioperative performance without any significant oncological efficacy. Due to certain limitations and the low level of evidence, further high-quality RCTs are required.
Similar content being viewed by others
References
Petryszyn P, Chapelle N, Matysiak-Budnik T (2020) Gastric cancer: where are we heading? Dig Dis. https://doi.org/10.1159/000506509
Arnold M, Abnet CC, Neale RE et al (2020) Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. https://doi.org/10.1053/j.gastro.2020.02.068
Smyth EC, Verheij M, Allum W et al (2016) Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol 27:v38–v49. https://doi.org/10.1093/annonc/mdw350
Komatsu S, Otsuji E (2019) Essential updates 2017/2018: recent topics in the treatment and research of gastric cancer in Japan. Ann Gastroenterol Surg 3:581–591. https://doi.org/10.1002/ags3.12284
Van Den Ende T, Ter Veer E, Machiels M et al (2019) The efficacy and safety of (Neo)adjuvant therapy for gastric cancer: a network meta-analysis. Cancers (Basel). https://doi.org/10.3390/cancers11010080
Japanese Gastric Cancer Association jgca@koto.kpu-m.ac.jp (2020) Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. https://doi.org/10.1007/s10120-020-01042-y
Tran TB, Worhunsky DJ, Norton JA et al (2015) Multivisceral resection for gastric cancer: results from the US gastric cancer collaborative. Ann Surg Oncol 22:840–847. https://doi.org/10.1245/s10434-015-4694-x
Cao B, Xiao A, Shen J et al (2020) An optimal surgical approach for suprapancreatic area dissection in laparoscopic D2 gastrectomy with complete mesogastric excision. J Gastrointest Surg. https://doi.org/10.1007/s11605-019-04467-8
Xiong B, Ma L, Huang W et al (2019) Efficiency of bursectomy in patients with resectable gastric cancer: an updated meta-analysis. Eur J Surg Oncol 45:1483–1492. https://doi.org/10.1016/j.ejso.2019.01.020
Mogal H, Fields R, Maithel SK, Votanopoulos K (2019) In patients with localized and resectable gastric cancer, what is the optimal extent of lymph node dissection—D1 versus D2 versus D3? Ann Surg Oncol 26:2912–2932. https://doi.org/10.1245/s10434-019-07417-5
Fujita J, Kurokawa Y, Sugimoto T et al (2012) Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial. Gastric Cancer 15:42–48. https://doi.org/10.1007/s10120-011-0058-9
Terashima M, Doki Y, Kurokawa Y et al (2017) Primary results of a phase III trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001). J Clin Oncol. https://doi.org/10.1200/JCO.2017.35.4_suppl.5
Hirao M, Kurokawa Y, Fujita J et al (2015) Long-term outcomes after prophylactic bursectomy in patients with resectable gastric cancer: final analysis of a multicenter randomized controlled trial. Surgery 157:1099–1105. https://doi.org/10.1016/j.surg.2014.12.024
Kurokawa Y, Fujiwara Y, Takiguchi S et al (2011) Randomized controlled trial of omental bursectomy for resectable cT2-3 gastric cancer. J Clin Oncol. https://doi.org/10.1200/jco.2011.29.4_suppl.72
Binboğa S, Binboga S (2018) Early morbidity and mortality in patients undergoing radical gastrectomy and bursectomy in gastric cancer [Mide Kanseri Nedeniyle Radikal Gastrektomi ve Bursektomi Yapılan Hastalarda Erken Dönem Morbidite ve Mortalitesi]. Med J Bakirkoy 14:398–402. https://doi.org/10.4274/BTDMJB.20180412014212
Imamura H, Kurokawa Y, Kawada J et al (2011) Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: results of a randomized controlled trial. World J Surg 35:625–630. https://doi.org/10.1007/s00268-010-0914-5
Kurokawa Y, Doki Y, Mizusawa J et al (2018) Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol 3:460–468. https://doi.org/10.1016/S2468-1253(18),30090-6
Eom BW, Joo J, Kim YW et al (2013) Role of bursectomy for advanced gastric cancer: result of a case-control study from a large volume hospital. Eur J Surg Oncol 39:1407–1414. https://doi.org/10.1016/j.ejso.2013.09.013
Kochi M, Fujii M, Kanamori N et al (2014) D2 gastrectomy with versus without bursectomy for gastric cancer. Am J Clin Oncol 37:222–226. https://doi.org/10.1097/COC.0b013e31825eb734
Shimada Y (2004) JGCA (The Japan Gastric Cancer Association). Gastric cancer treatment guidelines. Jpn J Clin Oncol 34:58
Japanese Gastric Cancer Association (2017) Japanese gastric cancer treatment guidelines (ver. 4). Gastric Cancer 20:1–19. https://doi.org/10.1007/s10120-016-0622-4
Kung C-H, Lindblad M, Nilsson M et al (2014) Postoperative pancreatic fistula formation according to ISGPF criteria after D2 gastrectomy in Western patients. Gastric Cancer 17:571–577. https://doi.org/10.1007/s10120-013-0307-1
Hu Z, Li Y, Zhang J et al (2020) Bursectomy versus nonbursectomy for gastric adenocarcinoma: a single-center, propensity-score matched cohort study in China. J Laparoendosc Adv Surg Tech A. https://doi.org/10.1089/lap.2019.0687
Nie R-C, Yuan S-Q, Chen S et al (2018) Bursectomy for advanced gastric cancer: an update meta-analysis. World J Surg Oncol 16:66. https://doi.org/10.1186/s12957-018-1354-1
Marano L, Polom K, Bartoli A et al (2018) Oncologic effectiveness and safety of bursectomy in patients with advanced gastric cancer: a systematic review and updated meta-analysis. J Invest Surg 31:529–538. https://doi.org/10.1080/08941939.2017.1355942
Shen W-S, Xi H-Q, Wei B, Chen L (2014) Effect of gastrectomy with bursectomy on prognosis of gastric cancer: a meta-analysis. World J Gastroenterol 20:14986–14991. https://doi.org/10.3748/wjg.v20.i40.14986
Li Y, Li Y, Wang K (2019) Bursectomy in gastric cancer surgery: a meta-analysis. Rev Invest Clin 71:98–105. https://doi.org/10.24875/RIC.18002622
Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097
Higgins JPT, Cochrane Collaboration (2019) Cochrane handbook for systematic reviews of interventions, 2nd edn. Wiley-Blackwell Publishing Ltd, Hoboken
Sterne JAC, Savović J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https://doi.org/10.1136/bmj.l4898
Sterne JA, Hernán MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https://doi.org/10.1136/bmj.i4919
Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13. https://doi.org/10.1186/1471-2288-5-13
Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815–2834
Tierney JF, Stewart LA, Ghersi D et al (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16. https://doi.org/10.1186/1745-6215-8-16
Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926. https://doi.org/10.1136/bmj.39489.470347.AD
Zhang W-H, Chen X-Z, Yang K et al (2015) Bursectomy and non-bursectomy D2 gastrectomy for advanced gastric cancer, initial experience from a single institution in China. World J Surg Oncol 13:332. https://doi.org/10.1186/s12957-015-0744-x
Ighor S, Olena K, Andrii L et al (2014) Bursectomy in gastric cancer surgery department of abdominal surgery, national cancer institute, Kyiv. Ukraine Ann Oncol 25:58. https://doi.org/10.1093/annonc/mdu165.73
Degiuli M, Sasako M, Ponti A et al (2014) Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 101:23–31. https://doi.org/10.1002/bjs.9345
Galizia G, Lieto E, De Vita F et al (2015) Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis. Surg (United States) 157:285–296. https://doi.org/10.1016/j.surg.2014.09.012
Mocellin S (2016) The effect of lymph node dissection on the survival of patients with operable gastric carcinoma. JAMA Oncol 2:1363–1364. https://doi.org/10.1001/jamaoncol.2016.2044
Karavokyros I, Michalinos A (2018) Favoring D2-lymphadenectomy in gastric cancer. Front Surg. https://doi.org/10.3389/fsurg.2018.00042
Songun I, Putter H, Kranenbarg EMK et al (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11:439–449. https://doi.org/10.1016/S1470-2045(10)70070-X
Hasegawa S, Kunisaki C, Ono H et al (2013) Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study. Gastric Cancer 16:383–388. https://doi.org/10.1007/s10120-012-0198-6
Blouhos K, Boulas KA, Hatzigeorgiadis A (2013) Bursectomy in gastric cancer surgery: surgical technique and operative safety. Updates Surg 65:95–101. https://doi.org/10.1007/s13304-013-0210-7
Kosaka T, Akiyama H, Makino H et al (2016) Impact of neoadjuvant chemotherapy among patients with pancreatic fistula after gastrectomy for advanced gastric cancer. Anticancer Res 36:1773–1777
Kodera Y, Sasako M, Yamamoto S et al (2005) Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 92:1103–1109. https://doi.org/10.1002/bjs.4979
Yu HW, Jung DH, Son S-Y et al (2013) Risk factors of postoperative pancreatic fistula in curative gastric cancer surgery. J Gastric Cancer 13:179–184. https://doi.org/10.5230/jgc.2013.13.3.179
Blouhos K, Boulas KA, Hatzigeorgiadis A (2015) Metastasis in lymph nodes on the anterior pancreatic surface of the body and tail: an extremely rare finding during bursectomy in extended surgery for gastric cancer. Updates Surg 67:97–98
Haverkamp L, Brenkman HJF, Ruurda JP et al (2016) The oncological value of omentectomy in gastrectomy for cancer. J Gastrointest Surg 20:885–890. https://doi.org/10.1007/s11605-016-3092-4
Sun F, Feng M, Guan W (2017) Mechanisms of peritoneal dissemination in gastric cancer. Oncol Lett 14:6991–6998. https://doi.org/10.3892/ol.2017.7149
Liu X, Cai H, Sheng W, Wang Y (2012) Long-term results and prognostic factors of gastric cancer patients with microscopic peritoneal carcinomatosis. PLoS ONE 7:e37284. https://doi.org/10.1371/journal.pone.0037284
Yamamura Y, Ito S, Mochizuki Y et al (2007) Distribution of free cancer cells in the abdominal cavity suggests limitations of bursectomy as an essential component of radical surgery for gastric carcinoma. Gastric Cancer 10:24–28. https://doi.org/10.1007/s10120-006-0404-5
Kidd JG, Rous P (1940) A transplantable rabbit carcinoma originating in a virus-induced papilloma and containing the virus in masked or altered form. J Exp Med 71:813–838. https://doi.org/10.1084/jem.71.6.813
Takeda J, Hashimoto K, Umetani H et al (1992) Invisible cardia cancer metastasis to the diaphragm. Kurume Med J 39:77–82. https://doi.org/10.2739/kurumemedj.39.77
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
Not applicable.
Informed consent to participate
Not applicable.
Informed consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Perivoliotis, K., Baloyiannis, I., Symeonidis, D. et al. The role of bursectomy in the surgical management of gastric cancer: a meta-analysis and systematic review. Updates Surg 72, 939–950 (2020). https://doi.org/10.1007/s13304-020-00801-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-020-00801-x